resistance mechanisms - Globe Thesis

Keyword [resistance mechanisms] Result: 101 - 120 \| Page: 6 of 8
101.	Studies On Antitumor And Resistance Mechanisms Of PARP Inhibitors
102.	Molecular Dynamics Simulation Survey Of The Drug Resistance Mechanisms And Structural Activation Of ALK
103.	Bufalin Induces Programmed Necrosis To Reverse The Resistance Mechanisms In Triple-negative Breast Cancer Cells
104.	Epidemiology And Echinocandin Resistance Mechanisms Of Candida Glabrata Complex Causing Invasive Infection In China:A Multicenter Study
105.	The Study Of The Role Of β-lactamases In The Sulbactam Resistance Mechanisms Of Acinetobacter Baumannii
106.	The Resistance Mechanisms Against Proteasome And Topoisomerase Inhibitors In Small Cell Lung Cancer
107.	Study On The Mechanism Of Cell Cycle Regulatory Protein 50A In Ovarian Cancer Stem Cells
108.	A Study On The Resistance Mechanism And Homology Of Carbapenem-resistant Serratia Marcescens In A Tertiary Hospital And Analysis Of Risk Factors For Clinical Infection
109.	Study On Resistance Mechanisms And Molecular Epidemiology Of Carbapenem Resistant Klebsiella Pneumoniae
110.	Research On Genomic Polymorphism And Antibiotic Resistance Of Helicobacter Pylori In Clinical Isolates
111.	Investigation Of Resistance Mechanisms And The Treatment Strategies For Carbapenem-Resistance Citrobacter Freundii
112.	Study On The Multidrug Resistance Mechanisms Of Salmonella Enterica Serovar Typhi And Carbapenem Resistant Enterobacteriaceae
113.	Drug-Resistance Features Of ESBLs-Producing Escherichia Coli And CTX-M-Mediated Drug-Resistance Mechanisms
114.	Analysis Of Antibiotic Resistance And Study Of Resistance Mechanisms On Carbapenem-resistant Acinetobacter Baumannii
115.	Analysis Of Clinical Characteristics And Antibacterial Resistance Mechanisms Of Carbapenem-resistant Klebsiella Pneumoniae
116.	The Molecular Epidemiology And Resistance Mechanisms Of Carbapenem-resistant Enterobacteriaceae In Chongqing
117.	The Relationship Between EGFR Gene Mutation In Tissues And Blood Form The Patients Of Lung Adenocarcinoma And Clinicopathological Features And Short-term Efficacy Of TKI Therapy
118.	Establishment Of A Lorlatinib-Resistant Cell Line Of Non-Small Cell Lung Cancer And Underlying Resistance Mechanisms
119.	Inhibitory Effect And Anti-drug Resistance Mechanisms Of Combined Teatment With 9R-P201/DOX To Hepatocellular Cells
120.	Molecular Epidemiology And Characterization Of Antimicrobial Resistance Mechanisms And Genetic Context Of Streptococcus Agalactiae
<<First <Prev Next> Last>> Jump to